Advertisement

Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair

  • Masanobu Nakajima
  • Hiroto Muroi
  • Maiko Kikuchi
  • Satoru Yamaguchi
  • Kinro Sasaki
  • Takashi Tsuchioka
  • Yusuke Takei
  • Ikuko Shibasaki
  • Hirotsugu Fukuda
  • Hiroyuki Kato
Original Article
  • 24 Downloads

Abstract

Objective

Definitive chemoradiotherapy is useful for locally advanced esophageal cancer. However, salvage esophagectomy is required when residual or recurrent tumor is evident after chemoradiotherapy. We performed salvage esophagectomy combined with partial aortic wall resection after thoracic endovascular aortic repair for aortic invasion, and we evaluated the results.

Methods

Four patients underwent esophagectomy combined with aortic wall resection after thoracic endovascular aortic repair because the lesion was diagnosed as stage T4b. We evaluated short-term outcomes, including duration of thoracic surgery, blood loss, duration of intubation, intensive care unit stay, and postoperative morbidity, as well as survival after salvage surgery.

Results

Lesions were resected with no intraoperative procedural adverse events. Mean thoracic operation time was 444 min, and mean thoracic blood loss was 506 g. In all patients, complete resection of the lesion was possible with no intraoperative adverse events. All patients were extubated on postoperative day 0, and all were discharged from the intensive care unit on postoperative day 1. One patient experienced grade II wound pain (bilateral chest pain), and another patient experienced difficult sputum expectoration (grade IIIA). The mean follow-up time was 19.8 months, and two patients were alive with no disease recurrence at the time of this report. However, the remaining two patients had died secondary to lymph node metastasis.

Conclusions

Salvage esophagectomy combined with partial aortic wall resection after thoracic endovascular aortic repair provides acceptable short-term outcomes. Future studies are needed to evaluate long-term survival and patient selection criteria.

Keywords

Esophageal cancer Salvage esophagectomy Thoracic endovascular aortic repair Chemoradiotherapy 

Notes

Acknowledgements

We thank Jane Charbonneau, DVM, and Emily Truckenbrod, DVM, from Edanz Group (http://www.edanzediting.com/ac) for editing drafts of this manuscript.

Compliance with ethical standards

Conflict of interest

Masanobu Nakajima, Hiroto Muroi, Maiko Kikuchi, Satoru Yamaguchi, Kinro Sasaki, Takashi Tsuchioka, Yusuke Takei, Ikuko Shibasaki, Hirotsugu Fukuda, and Hiroyuki Kato declare no conflicts of interest.

Ethical standard

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Before the operations, we obtained a general consent form from the patients for the use of their clinical data for clinical studies and registrations.

References

  1. 1.
    Fujita H. A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective. Ann Thorac Cardiovasc Surg. 2013;19:409–15.CrossRefGoogle Scholar
  2. 2.
    Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, et al. Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14:189–214.CrossRefGoogle Scholar
  3. 3.
    Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015;106:407–12.CrossRefGoogle Scholar
  4. 4.
    Rees J, Hurt CN, Gollins S, Mukherjee S, Maughan T, Falk SJ, et al. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Br J Cancer. 2015;113:603–10.CrossRefGoogle Scholar
  5. 5.
    Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–92.CrossRefGoogle Scholar
  6. 6.
    Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg. 2009;57:71–8.CrossRefGoogle Scholar
  7. 7.
    Nakajima M, Kato H, Muroi H, Kikuchi M, Takahashi M, Yamaguchi S, et al. Minimally invasive salvage operations for esophageal cancer after definitive chemoradiotherapy. Digestion. 2018;97:64–9.CrossRefGoogle Scholar
  8. 8.
    Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2017;42:1551–8.CrossRefGoogle Scholar
  9. 9.
    Ferrero E, Viazzo A, Ferri M, Rocca R, Pecchio A, Piazza S, et al. Acute management of aortoesophageal fistula and tracheoesophageal fistula treated by thoracic endovascular aortic repair and esophageal endoprosthesis: a case misdiagnosed as esophageal cancer. Ann Vasc Surg. 2011;25:1142.e1–5.Google Scholar
  10. 10.
    Matono S, Fujita H, Tanaka T, Nagano T, Nishimura K, Murata K, et al. Thoracic endovascular aortic repair for aortic complications after esophagectomy for cancer: report of three cases. Dis Esophagus. 2011;24:E36–40.CrossRefGoogle Scholar
  11. 11.
    Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. ed 7. Oxford: Wiley-Blackwell; 2010.Google Scholar
  12. 12.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefGoogle Scholar
  13. 13.
    Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg. 2013;61:330–5.CrossRefGoogle Scholar
  14. 14.
    Akutsu Y, Matsubara H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan. Surg Today. 2015;45:1360–5.CrossRefGoogle Scholar
  15. 15.
    Jamel S, Markar SR. Salvage esophagectomy: safe therapeutic strategy? J Thorac Dis. 2017;9:799–808.CrossRefGoogle Scholar
  16. 16.
    Swisher SG, Marks J, Rice D. Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation. Ann Cardiothorac Surg. 2017;6:144–51.CrossRefGoogle Scholar
  17. 17.
    Shimizu H, Hirahara N, Motomura N, Miyata H, Takamoto S. Current status of cardiovascular surgery in Japan, 2013 and 2014: a report based on the Japan Cardiovascular Surgery Database 5. Thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2017;65:671–8.CrossRefGoogle Scholar
  18. 18.
    Matsuda H. Treatment of uncomplicated type B aortic dissection. Gen Thorac Cardiovasc Surg. 2017;65:74–9.CrossRefGoogle Scholar
  19. 19.
    Chuter TA, Ivancev K, Lindblad B, Brunkwall J, Arén C, Risberg B. Endovascular stentgraft exclusion of an aortobronchial fistula. J Vasc Interv Radiol. 1996;7:357–9.CrossRefGoogle Scholar
  20. 20.
    Ishikawa N, Maruta K, Oi M, Iizuka H, Kawaura H, Omoto T. Thoracic endovascular repair for aorto-esophageal fistula in patients with esophageal carcinoma: report of 3 cases. Vasc Endovascular Surg. 2013;47:65–9.CrossRefGoogle Scholar
  21. 21.
    Okita Y, Yamanaka K, Okada K, Matsumori M, Inoue T, Fukase K, et al. Strategies for the treatment of aorto-oesophageal fistula. Eur J Cardiothorac Surg. 2014;46:894–900.CrossRefGoogle Scholar
  22. 22.
    Matsumoto A, Kanaoka Y, Baba T, Takizawa R, Hara M, Maeda K, et al. Result of thoracic endovascular aortic repair for patients with esophageal cancer. World J Surg. 2018;42:1551–8.CrossRefGoogle Scholar
  23. 23.
    Makino T, Yasuda T, Shiraishi O, Shiozaki H. Aortic stent-grafting facilitates a successful resection after neoadjuvant treatment of a cT4 esophageal cancer. J Thorac Cardiovasc Surg. 2014;148:e211-2.CrossRefGoogle Scholar
  24. 24.
    Watanabe Y, Kashihara S, Kiyonari N, Tsuji Y, Hisano K, Okada M. Combined resection of the thoracic esophagus and thoracic descending aorta. Jpn J Thorac Cardiovasc Surg. 1999;47:495–8.CrossRefGoogle Scholar
  25. 25.
    Sasahara H, Sueyoshi S, Tanaka T, Fujita H, Shirouzu K. Evaluation of an aortic stent graft for use in surgery on esophageal cancer involving the thoracic aorta: experimental study. Jpn J Thorac Cardiovasc Surg. 2004;52:231–9.CrossRefGoogle Scholar
  26. 26.
    Cohen C, Tessier W, Gronnier C, Renaud F, Pasquer A, Théreaux J, et al. FREGAT (French Eso-Gastric Tumors working group)—FRENCH (Fédération de Recherche en Chirurgie)—AFC (Association Française de Chirurgie). Salvage surgery for esophageal cancer: how to improve outcomes? Ann Surg Oncol. 2018;25:1277–86.CrossRefGoogle Scholar
  27. 27.
    Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2018

Authors and Affiliations

  • Masanobu Nakajima
    • 1
  • Hiroto Muroi
    • 1
  • Maiko Kikuchi
    • 1
  • Satoru Yamaguchi
    • 1
  • Kinro Sasaki
    • 1
  • Takashi Tsuchioka
    • 1
  • Yusuke Takei
    • 2
  • Ikuko Shibasaki
    • 2
  • Hirotsugu Fukuda
    • 2
  • Hiroyuki Kato
    • 3
  1. 1.First Department of SurgeryDokkyo Medical UniversityMibuJapan
  2. 2.Department of Cardiac and Vascular SurgeryDokkyo Medical UniversityMibuJapan
  3. 3.Fukushima Medical UniversityFukushimaJapan

Personalised recommendations